Browse
Submit Data
Databases
API
Help

Dataset Information

7 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Appropriate timing of urethral catheter removal in gastrointestinal surgery with epidural anesthesia: a randomized controlled trial

ABSTRACT: Interventions: Early group: The urethral catheter is removed on postoperative day 2 or 3, before removing the epidural anesthesia catheter. Late group: Urethral catheter removed after 2-24 hours of epidural catheter removal Primary outcome(s): Incidence of postoperative urinary retention (POUR) Study Design: Parallel Randomized

DISEASE(S): Gastric And Colorectal Cancer

PROVIDER: 2655209 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Study of the best epidural catheter location in ERAS protocol as perioperative medical care in rectum/sigmoid colon surgery

Project description:Interventions: Place the epidural catheter in the lower-thoracic level Place the epidural catheter in the mid-thoracic level Primary outcome(s): effect of postoperative analgesia and gastrointestinal recovery Study Design: Parallel Randomized

| 2620919 | ecrin-mdr-crc

Early and Late Removal of the Urinary Catheter After Rectum Resection

Project description:It was aimed to investigate the need for urinary retention and recatheterization in the postoperative period by removing the urinary catheter in patients undergoing low anterior resection, in the early or late period.

| 2387819 | ecrin-mdr-crc

Urinary catheter metagenome

Project description:Urinary catheter metagenome BTTDC Raw sequence reads

| PRJNA513418 | ENA

RNA-sequencing of Imiquimod-induced rat skin treated with or without epidural lidocaine injection

Project description:We use back skin of WT SD rats, or imiquimod(IMQ)-induced psoraisis-like rat model treated with or without epidural injection of 1% lidocaine. We isolate total RNA for RNA-sequencing.

2020-03-13 | GSE146891 | GEO

Urinary catheter metagenome BTTDD

Project description:Urinary catheter metagenome BTTDD Raw sequence reads

| PRJNA513452 | ENA

RNA-sequencing of Imiquimod-induced rat dorsal root ganglion (DRG) tissues treated with or without epidural lidocaine injection

Project description:We use dorsal root ganglion tissues of WT SD rats, or imiquimod(IMQ)-induced psoraisis-like rat model treated with or without epidural injection of 1% lidocaine. We isolated total RNA for RNA-sequencing.

2020-03-14 | GSE146927 | GEO

A clinical study to compare two techniques of pain relief(intravenous through blood route vs epidural through a catheter in back) after surgery for cancer treatment using reduction of tumour mass and chemotherapy at high temprature

Project description:Intervention1: Intravenous local anaesthetic and opioid infusion: Bolus dose of 1.5 mg/kg lignocaine over 15 mins, starting approximately 15 mins before surgical incision and fentanyl 0.5 mcg/kg, approximately 2 min before surgical incision will be administered. Following this patient will be receiving lignocaine infusion at 1 mg/kg/hr and fentanyl infusion at 0.5 mcg/kg/hr intraoperatively. Control Intervention1: Epidural Ropivacaine and fentanyl infusion: epidural catheter will be placed as per incision congruent technique before induction. Placement of the catheter will be checked by 3 ml of 2% lignocaine with adrenaline (1:200000). Epidural analgesia will be activated by 6 ml of Ropivacaine 0.2% and fentanyl (2 mcg/ml) approximately 15 min before surgical incision. Primary outcome(s): To evaluate postoperative analgesic efficacy of the analgesic technique.Timepoint: Immediately after extubation, 1 hour, 2 hour, 4 hour, 8 hour, 12 hour, 18 hour and 24 hour. Study Design: Randomized, Parallel Group, Active Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant Blinded

| 2597552 | ecrin-mdr-crc

Confirmation of Thoracic Epidural Space by the presence of waveform and the depth analysis by ultrasound

Project description:Primary outcome(s): Documentation of epidural waveform through epidural needle and catheter. Timepoint: Immediately after loss of resistance

| 2581401 | ecrin-mdr-crc

Analyses of lncRNA and mRNA profiles in the recurrent atrial fibrillation after Catheter Ablation

Project description:Our study aims to elucidate the role of lncRNA-mRNA regulatory networks in AF recurrence after catheter ablation. We performed RNA sequencing to profile the transcriptomes of 5 samples from atrial fibrillation recurrence and 5 samples from sinus rhythm maintenance. 96 differentially expressed genes (DEGs) and 203 differentially expressed long non-coding RNAs (DE-lncRNAs) were identified between atrial fibrillation recurrence group and sinus rhythm maintenance group. Gene Ontology (GO) analysis showed that DEGs were enriched in “regulation of immune response”, and “regulation of immune system process” for biological processes (BP), enriched in “extracellular matrix”, “cell-cell junction” for cellular components (CC), and enriched in “signaling adaptor activity”, “protein-macromolecule adaptor activity” for molecular functions (MF). For KEGG analysis, DEGs are associated with “PI3K-Akt signaling pathway”, “MAPK signaling pathway”. 9 hub genes (MMP9, IGF2, FGFR1, HSPG2, GZMB, PEG10, GNLY, COL6A1, and KCNE3) were identified through the Protein-Protein Interaction network. LncRNA-TMEM51-AS1-201 was identified as a core regulator and may impact AF recurrence after catheter ablation by regulating “COL6A1, FGFR1, HSPG2, and IGF2.”

2024-04-24 | GSE245886 | GEO

KDM5C safeguards the appropriate timing of early neurodevelopment

Project description:We generated human induced pluripotent cells from intellectual disability patients carrying the c.2T>C mutation in KDM5C (Called “Mutant”). We generated a paired, isogenic human iPS cell line (called “Corrected”) using CRISPR/Cas9 and PiggyBac gene-editing technologies and conducted neuronal differentiation based on “Yichen Shi et al. Nat. Protoc. 7, 1836–1846 (2012)” to define differences in gene expression between the Mutant and Corrected during neurodevelopment.

2023-10-13 | E-MTAB-7551 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data